BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T100000
DTEND;TZID=America/New_York:20231213T110000
DTSTAMP:20260410T165800
CREATED:20231108T123149Z
LAST-MODIFIED:20241024T182953Z
UID:10000706-1702461600-1702465200@staging.digitalinsights.supremeclients.com
SUMMARY:How to perform DNA-seq and resequencing data analyses using QIAGEN CLC Genomics Workbench
DESCRIPTION:In this webinar\, we’ll introduce algorithms required to perform data analysis for resequencing next-generation sequencing data. Together\, we’ll explore:  • Read mapper • Variant callers • Annotations and filters • Genome Browser  Bring any questions you may have\, and we will answer them during the webinar. 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-perform-dna-seq-data-analysis-with-clc-genomics-workbench-resequencing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_4_QDI_CLC_Challenger_Or55819-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T110000
DTEND;TZID=America/New_York:20231213T120000
DTSTAMP:20260410T165800
CREATED:20231201T164654Z
LAST-MODIFIED:20241024T182954Z
UID:10000710-1702465200-1702468800@staging.digitalinsights.supremeclients.com
SUMMARY:One tool to help biopharma accelerate cancer drug discovery and repurposing: A translational research use-case and discussion
DESCRIPTION:The development of new cancer drugs is challenging\, costly\, and time-consuming. As translational research on cancer diagnostics and genomic profiling rapidly evolves\, the ability to confidently and efficiently identify specific oncogenes and tumor suppressors involved in oncogenesis is becoming increasingly difficult. \nThis brief half-hour webinar is intended for biopharmaceutical and biotechnology professionals who need more efficient ways of discovering\, developing\, and repurposing drugs for oncology applications. During the session\, attendees will explore a demonstration and a use-case presented by Dr. Kyle Nilson\, providing insights into the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. \nHSMD is an exceptional resource for biopharmaceutical and biotechnology companies\, facilitating the confident evaluation of cancer-related genetic variations by granting access to real-world data. Powered by QIAGEN’s extensive artificial intelligence (AI)-enabled Knowledge Base\, robust curation team composed of over 100 expert curators (MD and PhD level)\, and data from QIAGEN’s professional variant interpretation service (previously N-of-One)\, HSMD encompasses a vast repository of over 4.7 million meticulously curated genetic alteration findings and variant data over 500\,000 somatic patient cases. Attendees will explore how HSMD enables biopharmaceutical and biotechnology companies to gain deeper insights into the molecular cancer profiles\, identify therapeutic options\, and develop strategies for finding new therapies for a particular cancer type or even for a particular patient. \nAttendees will: \n\nLearn what content sources power HSMD\nUnderstand how to use and apply HSMD for multiple applications\, including translational research and pharmaceutical development\nExamine a use case of how to use HSMD to accelerate research\, development and repurposing in cancer drug development programs\nReceive a complimentary 5-day trial of HSMD
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/one-tool-to-help-biopharma-accelerate-cancer-drug-discovery-and-repurposing-a-translational-research-use-case-and-discussion/
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1144_5_QDI_QCI_HSMD_GI646221430_16x9_59476_Large-1200px-1.jpg
END:VEVENT
END:VCALENDAR